Home | HIV Information | New Path To Therapeutic HIV Vaccine Discovered By Studying Immunologic Profile Of Rare HIV Controllers

New Path To Therapeutic HIV Vaccine Discovered By Studying Immunologic Profile Of Rare HIV Controllers

18 March, 2010 01:00:00 Medical News Today
Font size: Decrease font Enlarge font
Based on encouraging results from pre-clinical research, Bionor Immuno AS today announced intentions to take the therapeutic and potentially preventative HIV-vaccine candidate Vacc-C5 into a Phase I/II clinical trial. The research results indicate that Vacc-C5 may induce a protective antibody response in HIV patients similar to that found in patients with slow or non-progressing disease...

Comments (1 posted):

qinghua xia on 15 September, 2010 03:56:17
avatar
Based on encouraging results from pre-clinical research, Bionor Immuno AS today announced intentions to take the therapeutic and potentially preventative HIV-vaccine candidate Vacc-C5 into a Phase I/II clinical trial. The research results indicate that Vacc-C5 may induce a protective antibody response in HIV patients similar to that found in patients with slow or non-progressing disease...

Post your comment comment

Please enter the code you see in the image:

  • email Email to a friend
  • print Print version
  • Plain text Plain text
Tags
No tags for this article
Rate this article
0
Powered by Vivvo CMS v4.0